These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 17952155)

  • 21. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP; Card T; Logan RF; Leufkens HG
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surveillance of patients with inflammatory bowel diseases].
    Moshkowitz M; Kariv R; Half B; Vilkin A; Levi Z; Niv Y; Dotan I;
    Harefuah; 2011 Apr; 150(4):389-91, 417. PubMed ID: 22164923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
    Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
    Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk of cancer in chronic inflammatory bowel diseases].
    Fischbach W
    Leber Magen Darm; 1992 May; 22(3):96-101. PubMed ID: 1625513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignancy in Crohn's disease.
    Bernstein D; Rogers A
    Am J Gastroenterol; 1996 Mar; 91(3):434-40. PubMed ID: 8633487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chron's disease and cancer].
    Fornaro R; Frascio M; Denegri A; Stabilini C; Impenatore M; Mandolfino F; Lazzara F; Gianetta E
    Ann Ital Chir; 2009; 80(2):119-25. PubMed ID: 19681293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
    de Jong DJ; Nagengast FM
    Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2758-60. PubMed ID: 18232192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
    Canavan C; Abrams KR; Mayberry J
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1097-104. PubMed ID: 16611269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
    Diculescu M; Ciocîrlan M; Ciocîrlan M; Piţigoi D; Becheanu G; Croitoru A; Spanache S
    Rom J Gastroenterol; 2003 Dec; 12(4):283-6. PubMed ID: 14726972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
    Rutter MD; Saunders BP; Wilkinson KH; Rumbles S; Schofield G; Kamm MA; Williams CB; Price AB; Talbot IC; Forbes A
    Gut; 2004 Dec; 53(12):1813-6. PubMed ID: 15542520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory bowel disease and its association with colorectal cancer.
    Schechter S
    R I Med; 1995 Jun; 78(6):161-3. PubMed ID: 7626814
    [No Abstract]   [Full Text] [Related]  

  • 37. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The malignant side of chronic inflammatory bowel disease].
    West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.